Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
The transaction consisted of a primary capital commitment as well as the Actis buyout, according to a release. Financial terms of the deal have not been disclosed, but Indian media outlets have reported...
Xyb2b.com, a B2B platform that helps Chinese e-commerce companies source products from overseas, has completed an extended Series B round of funding worth $100 million.
Beijing Ubox Online Technology, a Chinese vending machine manager, has received RMB1.6 billion ($226 million) in funding from Ant Financial Services Group and Primavera Capital Group.
CITIC Capital has scaled up for its latest China fund, raising 75% more capital than in the previous vintage. The buyout-focused GP expects tighter liquidity to drive more corporate carve-outs
Tala, a US financial technology provider looking to expand its microlending operations in India, has raised a $110 million Series D round from a group including PayPal Ventures.